Pleural Diseases Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	165 Pages	Coherent Market Insights	July, 2023	CMI18107644

Best Price Guarantee
Price	from $4,500
Length	165 Pages
Publisher	Coherent Market Insights
Published Date	July, 2023
SKU	CMI18107644

Pleural Diseases Market, By Disease Type (Pleurisy, Pleural Effusion, Pneumothorax, Mesothelioma, Others), By Diagnostic Tools (Imaging Techniques, Molecular Diagnostics, Thoracoscopy and Pleuroscopy), By Treatment Modalities (Medications, Thoracentesis and Pleurodesis, Minimally Invasive Interventions, Surgical Interventions), By End-User (Hospitals and Clinics, Diagnostic Centers, Research and Academic Institutions), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung’s structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging pleural diseases.

Market Dynamics:

Increasing prevalence of respiratory diseases, technological advancements in diagnostic tools and imaging and focus on personalized medicine is anticipated to drive growth of the global pleural diseases market over the forecast period. Moreover, increasing investments in research and development is also expected to boost the growth of the global pleural diseases market over the forecast period. Advancements in minimally invasive interventions, emerging biomarkers and precision medicine, integration of artificial intelligence (AI) and machine learning (ml), telemedicine and remote monitoring are expected to create growth opportunities for the global pleural diseases market during the forecast period.

However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the pleural diseases market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the Pleural Diseases market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Pleural Diseases market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson, AstraZeneca, Novartis International AG, Roche Holding AG, Bristol Myers Squibb, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Bayer AG, Celgene Corporation,
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Pleural Diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Pleural Diseases market

Detailed Segmentation:

Global Pleural Diseases Market, By Disease Types:
Pleurisy
Pleural Effusion
Pneumothorax
Mesothelioma
Others
Global Pleural Diseases Market, By Diagnostic Tools:
Imaging Techniques
Molecular Diagnostics
Thoracoscopy and Pleuroscopy
Global Pleural Diseases Market, By Treatment Modalities:
Medications
Thoracentesis and Pleurodesis
Minimally Invasive Interventions
Surgical Interventions
Global Pleural Diseases Market, By End User:
Hospitals and Clinics
Diagnostic Centers
Research and Academic Institutions
Global Pleural Diseases Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East & South Africa
Company Profile:
Johnson & Johnson
AstraZeneca
Novartis International AG
Roche Holding AG
Bristol Myers Squibb
Merck & Co., Inc.
Pfizer Inc.
GlaxoSmithKline plc
Boehringer Ingelheim International GmbH
Sanofi
AbbVie Inc.
Eli Lilly and Company
Takeda Pharmaceutical Company Limited
Bayer AG
Celgene Corporation

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Diseases; Market Snapshot, By Diagnostic Tools; Market Snapshot, By Treatment Modalities; Market Snapshot, By End User; Market Snapshot, By Geography/Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Increasing Prevalence of Respiratory diseases; Restraints; Limited Availability of Expertise and Resources; Opportunities; Emerging Biomarkers and Precision Medicine; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Pleural Diseases Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Pleural Diseases Market , By Disease Types, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Pleurisy; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Pleural Effusion; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Pneumothelioma; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Mesothelioma; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Pleural Diseases Market , By Diagnostic Tools, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Imaging Techniques; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Molecular Diagnostics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Thoracoscopy and Pleuroscopy; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Global Pleural Diseases Market, By Treatment Modalities, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Medications; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Thoracentesis and Pleurodesis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Minimally Invasive Interventions; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Surgical Interventions; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Global Pleural Diseases Market , By End User, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Hospitals and Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Diagnostic Centers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Research and Academic Institutions; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Global Pleural Diseases Market , By Region, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2018 –2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools , 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools , 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools , 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools , 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
10. Competitive Landscape: Johnson & Johnson; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; AstraZeneca; Novartis International; Roche Holding AG; Bristol Myers Squibb; Merck & Co., Inc.; Pfizer Inc.; GlaxoSmithKline plc; Boehringer Ingelheim International GmbH; Sanofi; AbbVie Inc.; Eli Lily and Company; Takeda Pharmaceutical Company Limited; Bayer AG; Celgene Corporation; Analyst Views
11. Section: Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Pleural Diseases Market” - Global forecast to 2030